S. Sato et al. / Spectrochimica Acta Part A 70 (2008) 799–804
803
agents. For separation and purification, flash column chromatog-
raphy was performed on silica gel (230–400 mesh, Fuji-Silysia
Co., Ltd., BW-300). Melting points were determined on a
Shibayama micro-melting point apparatus and are uncorrected.
IR spectra were recorded on a Horiba FT-720 IR spectrom-
eter using a KBr disk. NMR spectra were recorded on a
Varian Inova 500 spectrometer using Me4Si as the inter-
nal standard. Mass spectral data were obtained by fast-atom
bombardment (FAB) using 3-nitrobenzyl alcohol (NBA) as
tal analyses were performed on a Perkin–Elmer PE 2400 II
instrument.
H-3), 7.04 (dd, 1H, J 2.2, 8.4 Hz, H-6), 7.10 (d, 1H, J 2.2 Hz, H-
8), 7.50 (d, 1H, J 8.4 Hz, H-5), 7.70 (d, 1H, J 9.6 Hz, H-4). 13C
NMR (CDCl3 + hydrazobenzene) δ 19.3 (CH3 × 4), 32.2 (C2ꢀ,
6ꢀ), 41.3 (C3ꢀ, 5ꢀ), 58.3 (C4ꢀ), 110.3, 116.0, 116.6, 119.8, 128.5,
142.8 (C4), 153.2 (C8), 154.6 (C9), 160.3 (C-2), 173.2 (car-
boxy). FAB-MS (m/z) 345 (M+H)+. Anal calcd. for C19H22NO5:
C, 66.26; H, 6.44; N, 4.07. Found: C, 66.34; H, 6.37;
N, 4.06.
4.2.3. 3-(7-Hydroxycoumarinyl-4-carboxymethyl)-2,2,5,5-
tetramethylpyrroline-1-oxyl (8)
Compound 8 was synthesized by condensation of 7-
hydroxycoumarinyl-4-acetic acid (2) with 3-hydroxylmethyl-
2,2,5,5-tetramethylpyrroline-1-oxyl (5) following in the same
procedure as was used for the synthesis of 6.
Nitroxide radicals (3, 4, and 5) were synthesized by usual
manner [18,19].
Data for 8: Yellow powder. Mp 110–112 ◦C. IR ν (KBr) 1749,
4.2.1. 4-(7-O-Coumarinyl)-oxycarbonyl-2,2,6,6-
tetramethylpyrroline-1-oxyl (6)
1
1712, 1610, 1566 cm−1. H NMR (CDCl3 + hydrazobenzene)
To a stirred solution of umbelliferone (3-hydroxycoumarin 1:
50 mg, 0.31 mmol) and 3-carboxy-2,2,5,5-tetramethylpyrroline-
1-oxyl (3: 68 mg, 0.40 mmol) in dry CH3CN (8 mL) in
an ice bath, DCC (76 mg, 0.37 mmol) and DMAP (3.7 mg,
0.031 mmol) were added and the mixture was stirred at room
temperature for 7 h. The resulting precipitates were filtered
through a celite pad. The filtrate was evaporated in vacuo
and then purified by silica gel column chromatography (2:1
hexane–AcOEt) to give 6 (73 mg, 72%) as a yellow powder,
which was recrystallized from MeOH.
δ 1.26 and 1.31 (s, each 6H, CH3 × 4), 4.86 (s, 2H, CH2),
6.88 (s, 1H, H-2ꢀ), 5.73 (s, 1H, olefinic H), 7.35 (m, 2H,
ArH), 7.64 (m, 2H, ArH), 8.55 (s, 1H, –CH ). 13C NMR
(CDCl3 + hydrazobenzene) δ (PROXYL moiety) 24.4 and 25.4
(each CH3 × 2), 61.2 (CH2), 68.3 and 70.3 (C2, 5), 149.1
(C3), 132.3 (C4), (coumarin moiety) 116.8, 117.8, 125.0,
129.6, and 155.2 (benzene ring), 138.6 (C4), 156.5 (C2–C O),
162.8 (C3–C O). FAB-MS (m/z) 343 (M+H)+. Anal calcd. for
C19H20NO5: C, 66.65; H, 5.89; N, 4.09. Found: C, 66.92; H,
6.12; N, 4.14.
Data for 6: Yellow needles. Mp 161–162 ◦C. IR ν (KBr)
2979, 2931, 1739, 1620, 1348, 1290, 1269, 1012 cm−1 1H
.
Acknowledgements
NMR (CDCl3 + hydrazobenzene) δ 1.31 and 1.46 (s, each 6H,
CH3 × 4), 6.40 (d, 1H, J 9.5 Hz, H-3), 6.88 (s, 1H, H-2ꢀ),
7.15 (dd, 1H, J 2.0, 8.5 Hz, H-6), 7.17 (d, 1H, J 2.0 Hz, H-8),
7.51 (d, 1H, J 8.5 Hz, H-5), 7.69 (d, 1H, J 9.5 Hz, H-4). 13C
NMR (CDCl3 + hydrazobenzene) δ 24.6 and 24.8 (CH3 × 4),
68.0 (C5ꢀ), 69.6 (C2ꢀ), 110.4, 116.0, 116.6, 119.8, 128.5, 129.3,
135.5 (C4ꢀ), 142.8 (C4), 153.0 (C8), 154.6 (C9), 160.3 (C2),
161.0 (carboxy). FAB-MS (m/z) 329 (M+H)+. Anal calcd. for
C18H18NO5: C, 65.84; H, 5.53; N, 4.27. Found: C, 65.90; H,
5.28; N, 4.24.
The authors wish to thank Professor T. Ogata for the use of
the ESR spectrometer and helpful discussions regarding the ESR
study, Professor H. Mizuguchi for the use of the fluorescence
spectrophotometer, and Professor T. Izumi for the use of the
UV–vis spectrometer.
References
[1] X.-F. Yang, X.-Q. Guo, Analyst 126 (2001) 1800–1804.
[2] N. Soh, Y. Katayama, M. Maeda, Analyst 126 (2001) 564–566.
[3] J.-L. Chen, S.-J. Zhuo, Y.-Q. Wu, F.Li.L. Freug, C.-Q. Zhu, Spectrochim.
Acta Part A 63 (2006) 438–443.
4.2.2. 3-(7-O-Coumarinyl)-oxycarbonyl-2,2,5,5-
tetramethylpiperidine-1-oxyl (7)
[4] E. Lozinsky, V.V. Martin, T.A. Berezina, A.I. Shames, A.L. Weis,
G.I. Liktenshtein, J. Biochem. Biophys. Methods 38 (1999) 29–
42.
[5] N.V. Blough, D.J. Simpson, J. Am. Chem. Soc. 110 (1988) 1915–
1917.
[6] J.A. Green II, L.A. Singer, J. Chem. Phys. 58 (1973) 2690–2695.
[7] S.A. Green, D.J. Simpson, G. Zhou, P.S. Ho, N.V. Blough, J. Am. Chem.
Soc. 112 (1990) 7337–7346.
[8] J.L. Gerlock, P.J. Zacmanidis, D.R. Bauer, D.J. Simpson, N.V.
Blough, I.T. Almeen, Free Radic. Res. Commun. 10 (1990) 119–
121.
[9] X.-F. Yang, X.-Q. Guo, Anal. Chim. Acta 434 (2001) 169–177.
[10] Y. Katayama, N. Soh, M. Maeda, Chemphyschem 2 (2001) 655–
661.
[11] H. Wang, D. Zhang, X. Guo, L. Zhu, Z. Shuai, D. Zhu, Chem. Commun.
(2004) 670–671.
[12] J.A. Green II, L.A. Singer, J. Am. Chem. Soc. 96 (1974) 2730–2732.
[13] S. Pou, Y.-I. Huang, A. Bhan, V.S. Bhadti, R.S. Hosmane, S.Y. Wu, G.-L.
Cao, G.M. Rosen, Anal. Biochem. 212 (1993) 85–90.
To a stirred solution of umbelliferone (3-hydroxycoumarin
1: 30 mg, 0.19 mmol) and 4-carboxy-2,2,6,6-tetramethyl-
piperidine-1-oxyl(3:41 mg, 0.21 mmol)indryCH2Cl2 (4.8 mL)
in an ice bath, DCC (39 mg, 0.19 mmol) and DMAP (2.3 mg,
0.019 mmol) were added and the mixture was stirred at room
temperature for 18 h. The resulting precipitates were filtered
through a celite pad. The filtrate was evaporated in vacuo
and then purified by silica gel column chromatography (1:1
hexane–AcOEt) to give 7 (55 mg, 84%) as an orange powder,
which was recrystallized from MeOH.
Data for 7: Orange needles. Mp 167–168 ◦C. IR ν
(KBr) 2964, 1747, 1730, 1626, 1142 cm−1
.
1H NMR
(CDCl3 + hydrazobenzene) δ 1.20 and 1.25 (s, each 6H,
CH3 × 4), 1.77 (t, 2H, J 12.8 Hz, CH2), 1.97 (m, 2H, CH2),
2.95 (m, 1H, CH–), 4.50 (s, 1H, NOH), 6.41 (d, 1H, J 9.6 Hz,